Get started
Author

Pierre Morel

Acute Hepatitis B in a Patient with Antibodies to Hepatitis B Surface Antigen Who Was Receiving Rituximab
2001 · Isabelle Dervite, Didier Hober, et al. · New England Journal of Medicine · 297
PDF
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
2023 · Steven P. Treon, Alessandra Tedeschi, et al. · Seminars in Hematology · 71
Treatment of Acute Promyelocytic Leukemia: A Report of 70 Cases
1991 · Pierre Fenaux, Jean Paul Pollet, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 68
Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis
2017 · Sarah Salomon, Caroline Guignant, et al. · Arthritis Research & Therapy · 47
PDF
Bendamustine rituximab (BR) versus ibrutinib (Ibr) as primary therapy for Waldenström macroglobulinemia (WM): An international collaborative study.
2022 · Jithma P. Abeykoon, Shaji Kumar, et al. · Journal of Clinical Oncology · 16
Peripheral T-cell Lymphoma with Eosinophilia Presenting as Monoarthritis: A Case Study
2002 · Marjan Daneshpouy, Dominique Bataille, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 12
Impact of MICA and NKG2D polymorphisms in HLA-fully matched related and unrelated hematopoietic stem cell transplantation
2018 · Marie-Joelle Apithy, Amandine Charbonnier, et al. · Bone Marrow Transplantation · 11
Incidence of Disease Transformation and Development of MDS/AML in 165 Patients with Waldenstrom’s Macroglobulinemia (WM) Treated with Fludarabine (F)-Based Regimen in Three Studies (French Cooperative Group on CLL/WM)
2007 · Veronique Leblond, Jerome Tamburini, et al. · Blood · 9
Lymphomes osseux primitifs : étude prospective de 28 cas
2000 · Christine Brousse, Elisabeth Baumelou, et al. · Revue du Rhumatisme · 6
Radiotherapy (WBRT) or Autologous Stem-Cell Transplantation (ASCT) for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Long-Term Results of the Intergroup Anocef-Goelams Randomized Phase II Precis Study
2021 · Caroline Houillier, Luc Taillandier, et al. · Blood · 3
Autologous Stem Cell Transplantation (ASCT) as Consolidation Therapy for Patients with Low-Intermediate (LI) Risk Diffuse Large B-Cell Lymphoma (DLBCL) and Overexpression of Bcl2 Protein. Results of the First Interim Analysis of the GELA Trial LNH98-B2.
2004 · Pierre Morel, Nicolas Mounier, et al. · Blood · 3
Azacytidine in refractory or relapsed AML after intensive chemotherapy (IC): results of the French ATU Program
2010 · Raphaël Itzykson, Sylvain Thépot, et al. · F1000Research · 2
EO2463 Peptide Immunotherapy in Patients with Newly Diagnosed Asymptomatic Follicular Lymphoma Results in Monotherapy Objective Clinical Responses Linked with Anti-Peptide Specific CD8 Memory T Cell Responses: The EONHL1-20/Sidney Study
2024 · Jose C. Villasboas Bisneto, Stephen D. Smith, et al. · Blood · 1
PDF
A20 Gene Deregulation In Waldenstrom's Macroglobulinemia.
2010 · Stephanie Poulain, Rachid Aijjou, et al. · Blood · 1
Long Term Responses to Fludarabine and Rituximab in Waldenstrom’s Macroglobulinemia
2008 · Steven Treon, Andrew Branagan, et al. · Blood · 1
MCL1 copy number gain is a recurrent mark of venetoclax resistance in patients with chronic lymphocytic leukemia
2025 · Carolyne Croizier, Manon Garcia, et al. · Blood
EO2463 (EO) peptide immunotherapy combined with rituximab (R) for first-line treatment of low-tumor burden follicular lymphoma (FL): A feasibility evaluation in Study EONHL1-20/sidney (NCT04669171)
2025 · Stephen Smith, Francesc Bosch Albareda, et al. · Blood
PDF
EO2463 (EO) peptide immunotherapy in patients (pts) with newly diagnosed asymptomatic follicular lymphoma (FL) and marginal zone lymphoma (MZL): Study EONHL1-20/sidney (NCT04669171) primary endpoint lugano objective response analysis
2025 · Jose Villasboas Bisneto, Reid Merryman, et al. · Blood
PDF
Preemptive Therapy with Venetoclax for High-Risk Stage a CLL Patients: First Analysis of Prevene, a Phase II Trial of the Filo Group
2024 · Luc-Matthieu Fornecker, Rémi Letestu, et al. · Blood
PDF
High Frequency of CNS Involvement in Transformed Waldenström Macroglobulinemia
2021 · Eric Durot, Lukshe Kanagaratnam, et al. · Blood
Immune complex diseases resulting from idiotypic or allogenic interactions
1984 · Michel Goldman, J. P. Lambert, et al. · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
Works count: 21
Citation count: 548
H-index: 8
I10-index: 7
Year
Topic
Type